News

Filter

Current filters:

Relafen

1 to 9 of 63 results

GSK to settle Relafen antitrust litigation

16-02-2004

GlaxoSmithKline, the world's second-largest drugmaker, has agreed to settle a US antitrust case involving…

GlaxoSmithKlineGSKNabumetoneRelafen

GSK settles Relafen antitrust litigation

16-02-2004

GlaxoSmithKline, the world's second-largest drugmaker, has agreed to settle a US antitrust case involving…

GlaxoSmithKlineGSKNabumetoneRelafen

Teva gains rights to GSK leukemia drug

07-07-2003

Israeli-based Teva Pharmaceutical Industries says that it has received all product rights relating to…

GlaxoSmithKlineGSKMercaptopurineNabumetonePurinetholRelafenTeva Pharmaceutical Industries

Teva settles nabumetone litigation with GSK

05-05-2003

Israel's Teva Pharmaceutical Industries has announced the settlement ofall litigation pending between…

GlaxoSmithKlineGSKNabumetoneRelafenTeva Pharmaceutical Industries

IVAX gets US OK for generic Relafen

03-02-2003

IVAX Corp has received US approval for nabumetone tablets in 500mg and750mg strengths, a generic version…

GlaxoSmithKlineGSKIvaxNabumetoneRelafen

1 to 9 of 63 results

COMPANY SPOTLIGHT

Menarini

Back to top